Ouvrages publiés en collaboration (1)
  1. 1. Taton, O., Bondue, B., & Roufosse, F. (2022). Hypereosinophilic syndromes and lung involvement.
    2.   Parties d'ouvrages collectifs (9)
  2. 1. Gelfand, E. E., Simon, D., Simon, H.-U., Thomas, P. A., Busse, W. W., Nair, P., Gauvreau, G. G., Denburg, J. J., Bivins-Smith, E. E., Jacoby, D., Davis, B. B., Rothenberg, M., Khoury, P., Klion, A., Lotfi, R., Spada, N., Lotze, M. T., Schleimer, R. R., Kato, A., Kern, R., Lavigne, M. M., Eppihimer, M. M., Roufosse, F., Le Moine, A., Massart, A., Benghiat, F., Lemaitre, P., Krahn, M., Bartoli, M., & Levy, N. (2013). Eosinophils in Human Disease. In Eosinophils in Health and Disease (pp. 431-536). Elsevier Inc. doi:10.1016/B978-0-12-394385-9.00013-4
  3. 2. Roufosse, F., Massart, A., Benghiat, F., Lemaitre, P., & Le Moine, A. (2012). Eosinophils and Allograft Rejection. In J. L. Lee & H. F. Rosenberg (Eds.), Eosinophils in Health and Disease. Academic Press, Elsevier.
  4. 3. Roufosse, F., Goldman, M., Cogan, E., & Lottenberg, R. (2009). Hypereosinophilia: Primary and Secondary. In Evidence-Based Hematology (pp. 221-228). John Wiley and Sons. doi:10.1002/9781444300857.ch27
  5. 4. Roufosse, F., Klion, A. D., & Weller, P. F. (2009). Treatment of the hypereosinophilic syndromes. In UpToDate. Waltham, MA: UpToDate, Basow, DS.
  6. 5. Roufosse, F., Klion, A. D., & Weller, P. F. (2009). Clinical manifestations, pathophysiology, and diagnosis of the hypereosinophilic syndromes. In UpToDate. Waltham, MA: UpToDate, Basow, DS.
  7. 6. Roufosse, F., Goldman, M., & Cogan, E. (2009). Hypereosinophilic syndromes. In Urticaria and Angioedema. Informa Healthcare publishers.
  8. 7. Roufosse, F., Goldman, M., & Cogan, E. (2008). Hyperesoinophilia: primary and secondary. In Evidence Based Hematology. Blackwell Publishers.
  9. 8. Roufosse, F., Goldman, M., & Cogan, E. (2004). Idiopathic hypereosinophilic syndrome. In Orphanet Encyclopedia (pp. 1-7).
  10. 9. Goldman, M., Bartholomé, E. J., & Roufosse, F. (2000). Mechanisms of action and clinical uses of type-I interferons. In A. Mantovani & P. Ghezzi (Eds.), Pharmacology of Cytokines (pp. 279-318). Oxford University press.
    11.   Articles dans des revues avec comité de lecture (78)
  11. 1. Khoury, P., Akuthota, P., Kwon, N., Steinfeld, J., & Roufosse, F. (2023). HES and EGPA: Two Sides of the Same Coin. Mayo Clinic proceedings, 98(7), 1054-1070. doi:10.1016/j.mayocp.2023.02.013
  12. 2. Wechsler, M. M., Hellmich, B., Cid, M. M., Jayne, D. R., Tian, X., Baylis, L. D., & Roufosse, F. (2023). Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis. Journal of allergy and clinical immunology, 151(6), 1415-1428. doi:10.1016/j.jaci.2023.03.011
    13. << Précédent 1 2 3 4 5 6 7 8 9 Suivant >>